Back to Journals » Clinical Interventions in Aging » Volume 12

Omega-3 fatty acid supplementation can improve both symptoms and signs of dry eye disease

Authors Kwon J, Han SB

Received 15 January 2017

Accepted for publication 23 January 2017

Published 3 March 2017 Volume 2017:12 Pages 485—486


Checked for plagiarism Yes

Editor who approved publication: Dr Richard Walker

Jae-Woo Kwon,1 Sang Beom Han2

1Department of Internal Medicine, 2Department of Ophthalmology, Kangwon National University Hospital, Kangwon National University Graduate School of Medicine, Chuncheon, South Korea
We read with great interest the article by Gatell-Tortajada1 entitled “Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study”. The prospective large-scale study was undoubtedly well designed and conducted, and the authors should be congratulated for successfully demonstrating that oral omega-3 fatty acid supplementation can be an effective treatment for dry eye symptoms.1
The authors showed that supplementation of omega-3 fatty acids improved dry eye signs, such as corneal erosion, tear film breakup time, and conjunctival hyperemia, suggesting that they can reduce ocular surface inflammation and also alleviate dry eye symptoms.1 Rashid et al2 also demonstrated that topical application of omega-3 fatty acids led to a decrease in dry eye signs and inflammatory changes at both cellular and molecular levels. 
View original paper by Gatell-Tortajada

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]